Building local momentum to expand access to radioligand therapy.

Radioligand therapy has progressed rapidly over the past decade, yet access remains unequal across regions. In many countries, the infrastructure, training and referral pathways needed to bring this treatment to people living with cancer are still being built.

To support this progress, the Oncidium foundation launched the Regional Radiotheranostics Summits, a series of focused events that gather healthcare leaders, oncologists, policymakers, nuclear medicine specialists, investors and industry representatives. Each edition is designed around the realities of its region, with a common goal: sharing practical knowledge to help establish radioligand therapy locally.

Every summit explores four key areas:

• Concept and landscape, to map where the field stands globally and regionally.
• Infrastructure and technology, covering the practical steps to set up a nuclear medicine centre.
• Clinical experience with radioligand therapy, through case studies and expert exchanges.
• Patient testimonials, keeping the experience of people living with cancer at the centre of the conversation.